Programme

Lecture Theatre 1B
2021-09-04
16:10-17:40
State Key Lab Meeting (1): GI cancer immunotherapy-basic to translational research
16:10
Immunotherapy in NASH-HCC
16:40
m6A and immunotherapy in CRC
17:10
T cell mediated anti-tumor therapy
Lecture Theatre 1B
2021-09-04
17:40-18:40
State Key Lab Meeting (2): Metabolism in GI cancer-molecular to clinic
17:40
Metabolic syndrome and colorectal cancer
18:00
m6A mediated glycolysis in colorectal cancer
18:20
SLC25A22 in Kras-mutant colorectal cancer
Lecture Theatre 1A
2021-09-05
09:00-10:30
State Key Lab Meeting (3): Microbiome and immunotherapy
09:00
Microbiome in checkpoint inhibitor immunotherapy
09:30
Probiotics in colorectal cancer
10:00
Gut microbiome in the immunopathogenesis of liver cancer
Lecture Theatre 1A
2021-09-05
11:00-12:30
State Key Lab Meeting (4): Host-microbiome interaction
11:00
Microbiota and HDAC activity
11:25
Microbiome and p53 function
11:50
Bacteria and host epigenetic alteration
12:10
Microbial heterogeneity in CRC
State Key Lab Meeting (1): GI cancer immunotherapy-basic to translational research
Lecture Theatre 1B
2021-09-04
16:10
16:10
Immunotherapy in NASH-HCC
16:40
m6A and immunotherapy in CRC
17:10
T cell mediated anti-tumor therapy
State Key Lab Meeting (2): Metabolism in GI cancer-molecular to clinic
Lecture Theatre 1B
2021-09-04
17:40
17:40
Metabolic syndrome and colorectal cancer
18:00
m6A mediated glycolysis in colorectal cancer
18:20
SLC25A22 in Kras-mutant colorectal cancer
State Key Lab Meeting (3): Microbiome and immunotherapy
Lecture Theatre 1A
2021-09-05
09:00
09:00
Microbiome in checkpoint inhibitor immunotherapy
09:30
Probiotics in colorectal cancer
10:00
Gut microbiome in the immunopathogenesis of liver cancer
State Key Lab Meeting (4): Host-microbiome interaction
Lecture Theatre 1A
2021-09-05
11:00
11:00
Microbiota and HDAC activity
11:25
Microbiome and p53 function
11:50
Bacteria and host epigenetic alteration
12:10
Microbial heterogeneity in CRC